Intuitive Surgical (NASDAQ:ISRG) Stock Price Expected to Rise, Leerink Partners Analyst Says
Intuitive Surgical (NASDAQ:ISRG – Get Free Report) had its target price hoisted by equities researchers at Leerink Partners ...
Leerink Partnrs Reduces Earnings Estimates for 908 Devices
Analysts at Leerink Partnrs cut their Q4 2025 earnings per share (EPS) estimates for 908 Devices in a note issued to ...
Vincerx Pharma enters at-the-market equity offering deal
Vincerx Pharma, Inc. (NASDAQ:VINC), a pharmaceutical company, announced today an agreement with H.C. Wainwright & Co., LLC to sell up to $30 million of its common stock in an at-the-market equity ...
Leerink Partners Remains a Buy on AnaptysBio (ANAB)
In a report released on January 16, David Risinger from Leerink Partners maintained a Buy rating on AnaptysBio (ANAB – Research Report). The ...
Investing16d
Leerink raises Progyny stock target, market perform rating on resilience
On Monday, Progyny (NASDAQ:PGNY) shares saw a change in their market prospects as Leerink Partners adjusted the company's price target. Analysts at Leerink Partners increased the price target on ...
Investing17d
Leerink raises Progyny stock target, market perform rating on resilience
On Monday, Progyny (NASDAQ:PGNY) shares saw a change in their market prospects as Leerink Partners adjusted the company's price target. Analysts at Leerink Partners increased the price target on ...
Business Insider17d
Leerink Partners Sticks to Its Buy Rating for Climb Bio (CLYM)
In a report released on January 9, Thomas Smith from Leerink Partners reiterated a Buy rating on Climb Bio (CLYM – Research Report). The company’s shares closed last Friday at $2.00.